Retinal vein occlusion is a common and potentially devastating retinal vascular disease that affects more than 16 million adults worldwide. Second only diabetic retinopathy, vein occlusions are one of the leading causes of blindness from retinal vascular disease.
This Focal Points module reviews the etiology, epidemiology, diagnosis and workup of RVO. Relevant clinical trials, recent advances in prognosis and the use of anti-VEGF agents are examined.
After completion of this module, you will be able to:
- Describe basic pathophysiology of retinal vein occlusions.
- Summarize essential ancillary testing in the diagnosis and workup of RVOs.
- List treatment options for management of RVOs.
- List key features of the relevant clinical trials that guide current treatment of RVOs.
- Describe a logical, stepwise approach to management of RVOs.
Authors: Jason N. Crosson, MD; John O. Mason III, MD
Consultants: Gelareh Abedi, MD; Manju L. Subramanian, MD
Focal Points issues are practical, hands-on discussions of the clinical issues you face daily. Each issue delivers high-quality, trusted ophthalmic information written and reviewed by leading experts.
Subscribers receive 12 issues a year, plus access to the Focal Points digital archive.
To access this issue from your laptop or desktop computer, log in to www.aao.org/myonlineproducts with your Academy username and password.
To access this issue from your smartphone or tablet, use the free AAO eBooks app.
The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Academy of Ophthalmology designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.